CHARLOTTE ALLERTON
Head of Research and Development
Head of Research & Development and Chief Scientific Officer for ViiV Healthcare, Charlotte Allerton oversees the discovery and clinical development of our pipeline assets in support of our overall company strategy to deliver meaningful advances in treatment and care for people living with HIV.
Charlotte is a globally accomplished scientist who is known for her strong and compassionate leadership and successful track record in drug discovery and development. Her career started at Pfizer where she joined as a medicinal chemist and most recently served as Senior Vice President and Head of Preclinical and Translational Science. A driving force behind the discovery and development of Paxlovid – the first oral antiviral for COVID19 -- she and the team earned multiple honors, including the prestigious Prix Galien and ACS Heroes of Chemistry awards. For the last four years, she has been an important member of the ViiV Board of Directors and strongly believes in our purpose and patient focus.
Charlotte's contributions to the field have been recognized. She is an honorary fellow of the Royal Society of Chemistry. In 2020, she received the Healthcare Businesswomen's Association Luminary award, and in 2024 she was recognized on the Medicine Maker Power List. Charlotte earned a Bachelor of Science degree from the University of Nottingham and a Master of Philosophy in organic chemistry from the University of Cambridge.
Our Executive Team
YOU MAY ALSO BE INTERESTED IN
Together we are engaged in the HIV response throughout the world, supported by a team of over 1,100 dedicated ViiV Healthcare staff working across the globe.
Discover more about who we are, the work we do and what we're doing to advance HIV science, support the delivery of HIV treatment and care; and work with partners to address the stigma and discrimination faced by people living with HIV.
NP-GBL-HVX-COCO-220025 April 2026
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
